Not applicableEnded earlyNCT05709535What this trial is testingPSMA-PET/CT RegistryWho this might be right forProstate Cancer AHS Cancer Control Alberta 128
Early research (Phase 1)Looking for participantsNCT06208735What this trial is testingCLIC-2201 for the Treatment of Relapsed/Refractory B Cell MalignanciesWho this might be right forB-Cell LeukemiaNon-Hodgkin's LymphomaB-cell Acute Lymphoblastic Leukemia+5 more British Columbia Cancer Agency 24
Testing effectiveness (Phase 2)Study completedNCT02464657What this trial is testingStudy of Idarubicin, Cytarabine, and Nivolumab in Patients With High-Risk Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML)Who this might be right forLeukemiaAcute Myeloid LeukemiaMyelodysplastic Syndrome M.D. Anderson Cancer Center 44
Not applicableLooking for participantsNCT04688801What this trial is testingAjuvant Chemotherapy and Immunotherapy in Patients With Esophageal, Esophageal- Gastric Junction CancerWho this might be right forEsophageal CancerGastroesophageal CancerImmunotherapy+1 more The Second Hospital of Shandong University 200
Not applicableLooking for participantsNCT05740839What this trial is testingHigh-Intensity Interval Exercise in Young Adult Survivors of Pediatric Brain Tumors: A Pilot Feasibility StudyWho this might be right forPediatric Brain Tumor Dana-Farber Cancer Institute 30
Not applicableStudy completedNCT03121300What this trial is testingFunctional Imaging in Lung SBRTWho this might be right forLung Cancer University of Michigan Rogel Cancer Center 33
Large-scale testing (Phase 3)Study completedNCT00008203What this trial is testingComparison of Biological Therapies Following Combination Chemotherapy and Bone Marrow or Peripheral Stem Cell Transplantation in Women With Stage II or Stage III Breast CancerWho this might be right forBreast Cancer Herbert Irving Comprehensive Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT07243470What this trial is testingCombination of Tarlatamab and Temozolomide in Patients With Central Nervous System TumorsWho this might be right forGliomaCNS Tumor, AdultCNS Tumor, Childhood Centre Leon Berard 70
Not applicableUnknownNCT02053805What this trial is testingProstate Cancer Screening Among Men With High Risk Genetic PredispositionWho this might be right forBRCA1 SyndromeBRCA2 SyndromeLynch Syndrome Rabin Medical Center 200
Testing effectiveness (Phase 2)UnknownNCT03759496What this trial is testingEfficacy of Durvalumab in Non-muscle-invasive Bladder CancerWho this might be right forBladder Cancer Hellenic GenitoUrinary Cancer Group 39
Large-scale testing (Phase 3)Study completedNCT02926196What this trial is testingAdjuvant Treatment for High-risk Triple Negative Breast Cancer Patients With the Anti-PD-l1 Antibody AvelumabWho this might be right forTriple Negative Breast Neoplasms Istituto Oncologico Veneto IRCCS 474
Testing effectiveness (Phase 2)Study completedNCT04311580What this trial is testingIntravesical Electromotive Mitomycin After Bacillus Calmette-Guérin FailureWho this might be right forBladder Cancer University of Rome Tor Vergata 52
Testing effectiveness (Phase 2)Looking for participantsNCT07455903What this trial is testingAssessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CTWho this might be right forProstate CancerLocalized Prostate Carcinoma Baptist Health South Florida 50
Not applicableEnded earlyNCT00896961What this trial is testingEF5 to Evaluate Tumor Hypoxia in Patients With High-Grade Soft Tissue Sarcoma or Mouth CancerWho this might be right forStage I Adult Soft Tissue SarcomaStage I Squamous Cell Carcinoma of the Lip and Oral CavityStage II Adult Soft Tissue Sarcoma+3 more National Cancer Institute (NCI) 120
Not applicableStudy completedNCT00815113What this trial is testingScreening for Gastric Cancer in High-risk PopulationWho this might be right forGastric Cancer Rabin Medical Center 80
Early research (Phase 1)Temporarily pausedNCT06888323What this trial is testingTesting an Anti-cancer Radio-Active Immunotherapy Called Lintuzumab Ac225 in Patients With High-Risk Myelodysplastic Syndrome That Has Not Responded to Other TreatmentWho this might be right forRefractory Myelodysplastic Syndrome National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)Looking for participantsNCT07460362What this trial is testingGlofitamab Combined With Lenalidomide in High Risk Patients With Relapsed or Refractory Mantle Cell LymphomaWho this might be right forMCLRelapsed or Refractory Mantle Cell Lymphoma (MCL) Peking University Third Hospital 43
Not applicableStudy completedNCT00030823What this trial is testingVaccine Therapy in Treating Patients at High Risk for Breast Cancer RecurrenceWho this might be right forBreast Cancer Memorial Sloan Kettering Cancer Center 14
Not applicableLooking for participantsNCT06896370What this trial is testingAn Observational Study for Gastric Cancer in Carriers of High Risk Helicobacter PyloriWho this might be right forGastric (Stomach) CancerHelicobacter Infection Fudan University 3,000
Testing effectiveness (Phase 2)Study completedNCT00006373What this trial is testingCombination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's LymphomaWho this might be right forLymphoma H. Lee Moffitt Cancer Center and Research Institute 27